These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 18759645

  • 1. Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom study.
    Pierce D, Dixon CM, Wigal SB, McGough JJ.
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):355-64. PubMed ID: 18759645
    [Abstract] [Full Text] [Related]

  • 2. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D, Wigal S, Swanson J, Hirsch S, Ottolini Y, Dariani M, Roffman M, Zeldis J, Cooper T.
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [Abstract] [Full Text] [Related]

  • 3. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ, COMACS Study Group.
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [Abstract] [Full Text] [Related]

  • 4. Effects of application to two different skin sites on the pharmacokinetics of transdermal methylphenidate in pediatric patients with attention-deficit/hyperactivity disorder.
    González MA, Campbell D, Rubin J.
    J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):227-32. PubMed ID: 19519257
    [Abstract] [Full Text] [Related]

  • 5. Methylphenidate transdermal system: In attention-deficit hyperactivity disorder in children.
    Anderson VR, Scott LJ.
    Drugs; 2006 Jun; 66(8):1117-26. PubMed ID: 16789796
    [Abstract] [Full Text] [Related]

  • 6. Single- and multiple-dose pharmacokinetics of methylphenidate administered as methylphenidate transdermal system or osmotic-release oral system methylphenidate to children and adolescents with attention deficit hyperactivity disorder.
    Pierce D, Katic A, Buckwalter M, Webster K.
    J Clin Psychopharmacol; 2010 Oct; 30(5):554-64. PubMed ID: 20814325
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Methylphenidate blood levels and therapeutic response in children with attention-deficit hyperactivity disorder: I. Effects of different dosing regimens.
    Teicher MH, Polcari A, Foley M, Valente E, McGreenery CE, Chang WW, McKay G, Midha KK.
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):416-31. PubMed ID: 16958567
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder.
    Arnold LE, Lindsay RL, Conners CK, Wigal SB, Levine AJ, Johnson DE, West SA, Sangal RB, Bohan TP, Zeldis JB.
    J Child Adolesc Psychopharmacol; 2004 Aug; 14(4):542-54. PubMed ID: 15662146
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of a methylphenidate transdermal system versus t.i.d. methylphenidate in a laboratory setting.
    Pelham WE, Waxmonsky JG, Schentag J, Ballow CH, Panahon CJ, Gnagy EM, Hoffman MT, Burrows-MacLean L, Meichenbaum DL, Forehand GL, Fabiano GA, Tresco KE, Lopez-Williams A, Coles EK, González MA.
    J Atten Disord; 2011 Jan; 15(1):28-35. PubMed ID: 20439487
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder.
    Brams M, Mao AR, Doyle RL.
    Postgrad Med; 2008 Sep; 120(3):69-88. PubMed ID: 18824827
    [Abstract] [Full Text] [Related]

  • 16. A dose-ranging study of a methylphenidate transdermal system in children with ADHD.
    Pelham WE, Manos MJ, Ezzell CE, Tresco KE, Gnagy EM, Hoffman MT, Onyango AN, Fabiano GA, Lopez-Williams A, Wymbs BT, Caserta D, Chronis AM, Burrows-Maclean L, Morse G.
    J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):522-9. PubMed ID: 15908834
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system.
    Manos M, Frazier TW, Landgraf JM, Weiss M, Hodgkins P.
    Curr Med Res Opin; 2009 Dec; 25(12):3001-10. PubMed ID: 19849639
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of methylphenidate in preschoolers with attention-deficit/hyperactivity disorder.
    Wigal SB, Gupta S, Greenhill L, Posner K, Lerner M, Steinhoff K, Wigal T, Kapelinski A, Martinez J, Modi NB, Stehli A, Swanson J.
    J Child Adolesc Psychopharmacol; 2007 Apr; 17(2):153-64. PubMed ID: 17489710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.